Revolution Beauty have announced the acquisition of Medichem Manufacturing Ltd, exercising a call option that was flagged at the IPO. The acquisition is Revolution’s first and provides the Group with its own fully owned and vertically integrated manufacturing facility. The deal is expected to be significantly earnings enhancing in FY23E and beyond, reflected in a 15% upgrade to our FY23E and FY24E EPS forecasts today.
